US HB71 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 9 2023 - 25% progression
Action: 2023-01-09 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 9 2023 - 25% progression
Action: 2023-01-09 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to exempt from regulation as devices non-invasive diagnostic devices, and for other purposes.
Title
Medical Innovation Acceleration Act of 2023
Sponsors
| Rep. Andy Biggs [R-AZ] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-01-09 | House | Referred to the House Committee on Energy and Commerce. |
| 2023-01-09 | House | Referred to the Subcommittee on Health. |
| 2023-01-09 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/71/all-info |
| Text | https://www.congress.gov/118/bills/hr71/BILLS-118hr71ih.pdf |
